Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Starbucks Corp (SBUX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Starbucks Corp — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.74 (market cap $25.27B), while Starbucks Corp trades at $91.5 (market cap $106.26B). The key difference: Starbucks Corp is far larger — about 4.2× Royalty Pharma plc Class A Ordinary Shares's market cap, and Starbucks Corp pays the higher dividend (2.7%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Starbucks Corp for 190 Days on average.
| RPRX | SBUX | |
|---|---|---|
Market Cap | $25.27B | $106.26B |
Volume | 3,671,183 | 30,248,434 |
Sector | Health | Consumer Cyclical |
52-Week High | $63.96 | $108.55 |
52-Week Low | $35.44 | $78.46 |
Typical Hold Time | 0 Days | 190 Days |
Enterprise Value | $32.50B | $125.08B |
Dividend Yield | 1.66% | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Starbucks (SBUX) trades at $93.58, down 2.63% on the day, as the company navigates a strategic restructuring with 250 North American store closures. The stock shows mixed technical signals with bearish moving averages but neutral oscillators. Fundamentally, SBUX maintains stable revenue growth but faces margin compression, with net income declining to $1.86B in 2025. Analyst consensus remains positive with a $115.50 price target, though recent news highlights operational challenges and geopolitical tensions.
The outlook for SBUX balances near-term headwinds from restructuring costs against long-term growth potential in international markets. Investment opportunities include strong brand equity and dividend consistency, while risks involve labor relations, Chinese market exposure, and execution of the store optimization strategy. The current valuation at 53.88x P/E requires sustained earnings recovery to justify upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Starbucks Corp
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →
